GSK Plc’s blood cancer drug Blenrep has won approval from the UK medicines regulator, opening the door to the return of a treatment that was withdrawn from the market about two years ago.
Source link
2025-04-19
A World of Free Speech
GSK Plc’s blood cancer drug Blenrep has won approval from the UK medicines regulator, opening the door to the return of a treatment that was withdrawn from the market about two years ago.
Source link
